米维布塞【1445993-26-9】产品图
文献支持

米维布塞【1445993-26-9】

收藏
  • ¥281 - 6144
  • TargetMol
  • T3712
  • 2026年07月07日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • CAS号:

      1445993-26-9

    • 规格:

      1mg/1mLx10mM(inDMSO)/5mg/10mg/25mg/50mg/100mg/200mg

    规格:1mg产品价格:¥281.0
    规格:1mLx10mM(inDMSO)产品价格:¥636.0
    规格:5mg产品价格:¥629.0
    规格:10mg产品价格:¥1024.0
    规格:25mg产品价格:¥2120.0
    规格:50mg产品价格:¥3184.0
    规格:100mg产品价格:¥4392.0
    规格:200mg产品价格:¥6144.0

    Product Introduction

    Bioactivity

    名称 Mivebresib
    描述 Mivebresib (ABBV-075), also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-containing protein) with potential antineoplastic activity. Upon administration, the bromodomain inhibitor ABBV-075 binds to the acetyl-lysine binding site in the BRD of certain BRD-containing protein(s), thereby preventing the interaction between those proteins and acetylated histones. This disrupts chromatin remodeling, prevents the expression of certain growth-promoting genes, and leads to an inhibition of cell growth in susceptible tumors. Also a potent inhibitor of MYC and the TMPRSS2-ETS fusion proteins.
    体外活性 Mivebresib在来源于实体瘤、白血病和淋巴瘤的癌症细胞系上的细胞活性检测中展示活性。它能够干扰细胞周期控制,导致G1期阻滞后进入衰老状态,抑制致癌因子从而触发凋亡,并有可能针对肿瘤微环境以提供额外治疗效益[1]。
    体内活性 ABBV-075在非小细胞肺癌、小细胞肺癌、胰腺癌、乳腺癌、前列腺癌、头颈癌、多发性骨髓瘤、弥漫大B细胞淋巴瘤和白血病的侧腹移植小鼠模型中,与标准治疗药物相比,具有相当或更优的疗效[1]。
    存储条件 Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
    溶解度 H2O : < 1 mg/mL (insoluble or slightly soluble)
    10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (21.76 mM), Suspension.
    10% DMSO+90% Saline : < 10 mg/mL (21.76 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
    Ethanol : < 1 mg/mL (insoluble or slightly soluble)
    DMSO : 250 mg/mL (544.11 mM), Sonication is recommended.
    关键字 Mivebresib | Inhibitor | inhibit | EpigeneticReaderDomain | Epigenetic Reader Domain | BET | Apoptosis | ABBV075 | ABBV 075
    相关产品 Formamide | Urea | Sodium Molybdate | Dimethyl phthalate | Aceglutamide | Alginic acid | Cysteamine hydrochloride | Metronidazole | Sildenafil citrate | Citric Acid Triammonium | Stavudine | Tamoxifen
    相关库 Inhibitor Library | Anti-Cancer Active Compound Library | Bioactive Compound Library | Bioactive Compounds Library Max | Chromatin Modification Compound Library | Failed Clinical Trials Compound Library | Highly Selective Inhibitor Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-Cancer Clinical Compound Library | Target-Focused Phenotypic Screening Library | Anti-Cancer Drug Library

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    官网有文献
    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥580
    MedChemExpress LLC
    2025年12月05日询价
    ¥979
    北京沃比森科技有限公司
    2026年09月03日询价
    ¥1048
    爱必信(上海)生物科技有限公司
    2025年07月01日询价
    询价
    伯乐生命医学产品(上海)有限公司 Bio-Rad Laboratories
    2026年06月23日询价
    ¥3904
    深圳欣博盛生物科技有限公司
    2026年10月28日询价
    文献支持
    米维布塞【1445993-26-9】
    ¥281 - 6144